GB2040681B - Use in the treatment of hypertension and intestinal disorders of certain n - aryl - n - (2-imidazolidinylidene)-urea - Google Patents

Use in the treatment of hypertension and intestinal disorders of certain n - aryl - n - (2-imidazolidinylidene)-urea

Info

Publication number
GB2040681B
GB2040681B GB7944114A GB7944114A GB2040681B GB 2040681 B GB2040681 B GB 2040681B GB 7944114 A GB7944114 A GB 7944114A GB 7944114 A GB7944114 A GB 7944114A GB 2040681 B GB2040681 B GB 2040681B
Authority
GB
United Kingdom
Prior art keywords
imidazolidinylidene
hypertension
urea
aryl
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7944114A
Other versions
GB2040681A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
McNeilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/972,579 external-priority patent/US4229462A/en
Priority claimed from US05/972,580 external-priority patent/US4239768A/en
Application filed by McNeilab Inc filed Critical McNeilab Inc
Publication of GB2040681A publication Critical patent/GB2040681A/en
Application granted granted Critical
Publication of GB2040681B publication Critical patent/GB2040681B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30—Isothioureas
    • C07C335/38—Isothioureas containing any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB7944114A 1978-12-22 1979-12-21 Use in the treatment of hypertension and intestinal disorders of certain n - aryl - n - (2-imidazolidinylidene)-urea Expired GB2040681B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/972,579 US4229462A (en) 1978-12-22 1978-12-22 Method for controlling hypertension and compositions
US05/972,580 US4239768A (en) 1978-12-22 1978-12-22 Method for relieving irritable bowel syndrome symptoms

Publications (2)

Publication Number Publication Date
GB2040681A GB2040681A (en) 1980-09-03
GB2040681B true GB2040681B (en) 1983-04-13

Family

ID=27130555

Family Applications (2)

Application Number Title Priority Date Filing Date
GB7944114A Expired GB2040681B (en) 1978-12-22 1979-12-21 Use in the treatment of hypertension and intestinal disorders of certain n - aryl - n - (2-imidazolidinylidene)-urea
GB08221517A Expired GB2113204B (en) 1978-12-22 1982-07-26 N-(2,6-disubstituted phenyl)-n'-(2-imidazolidinylidene) ureas

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB08221517A Expired GB2113204B (en) 1978-12-22 1982-07-26 N-(2,6-disubstituted phenyl)-n'-(2-imidazolidinylidene) ureas

Country Status (23)

Country Link
AT (1) AT373878B (en)
AU (2) AU532332B2 (en)
CA (1) CA1127651A (en)
CH (1) CH647236A5 (en)
DE (1) DE2951213A1 (en)
DK (1) DK548179A (en)
ES (1) ES8101558A1 (en)
FI (1) FI66354C (en)
FR (2) FR2444462B1 (en)
GB (2) GB2040681B (en)
GR (1) GR68018B (en)
HU (1) HU183013B (en)
IL (1) IL59019A (en)
IT (1) IT1126839B (en)
NL (1) NL7909265A (en)
NO (1) NO794249L (en)
NZ (1) NZ192453A (en)
PH (1) PH16571A (en)
PT (1) PT70624A (en)
SE (1) SE7910612L (en)
SU (1) SU971098A3 (en)
YU (1) YU314979A (en)
ZW (1) ZW25379A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
US11516649B2 (en) * 2018-10-29 2022-11-29 Apple Inc. Mechanism to activate and manage a standalone device for cellular service

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1296962A (en) * 1960-08-05 1962-06-22 Geigy Ag J R New 2-imino-1.3-di-aza compounds and their preparation
NL267923A (en) * 1960-08-05

Also Published As

Publication number Publication date
AU5378079A (en) 1980-06-26
FR2445321B1 (en) 1983-08-26
SU971098A3 (en) 1982-10-30
IT7951164A0 (en) 1979-12-21
FR2444462A1 (en) 1980-07-18
GB2113204B (en) 1984-02-01
FR2444462B1 (en) 1986-08-29
FI794036A (en) 1980-06-23
GB2040681A (en) 1980-09-03
ES487159A0 (en) 1980-12-16
FI66354B (en) 1984-06-29
IL59019A (en) 1984-05-31
NO794249L (en) 1980-06-24
GR68018B (en) 1981-10-27
IL59019A0 (en) 1980-03-31
NZ192453A (en) 1982-09-07
ZW25379A1 (en) 1981-07-22
AU566013B2 (en) 1987-10-08
AU532332B2 (en) 1983-09-29
CH647236A5 (en) 1985-01-15
PT70624A (en) 1980-01-01
SE7910612L (en) 1980-06-23
AU1640083A (en) 1983-11-17
AT373878B (en) 1984-02-27
HU183013B (en) 1984-04-28
FI66354C (en) 1984-10-10
CA1127651A (en) 1982-07-13
FR2445321A1 (en) 1980-07-25
YU314979A (en) 1983-02-28
DK548179A (en) 1980-06-23
ES8101558A1 (en) 1980-12-16
DE2951213A1 (en) 1980-07-10
GB2113204A (en) 1983-08-03
ATA808979A (en) 1983-07-15
NL7909265A (en) 1980-06-24
IT1126839B (en) 1986-05-21
PH16571A (en) 1983-11-18

Similar Documents

Publication Publication Date Title
ZA804180B (en) Medicaments for the treatment of disorders in lipometabolism and their use
ZA79204B (en) Cleansing pad and method of making the same
GB2013495A (en) Therapeutic method for the treatment of hyperlipodaemias and hyperlipoproteinaemias
ZA791728B (en) Cerebral therapeutic agent and its use
GB2016457B (en) Iodopropargyl derivatives their use and preparation
EP0069232A3 (en) Purified antineoplaston fractions and methods of treating neoplastic disease
EP0275668A3 (en) Use of ketone derivatives in the treatment of cognitive disorders
GB2016928B (en) Splint and stretcher
PH25019A (en) New benzamides and their use in treating gastrointestinal disorders
GB2071091B (en) Acyl-derivatives of carnitine and the therapeutic use thereof
AU530790B2 (en) Triazinones and their use in treating gastrointestinal disorders
ZA815346B (en) New medicament belonging to the family of glycosylglucans and its application in gastro-enterology,particularly in the treatment of disorders of the colon
ZA774152B (en) Improvements in and relating to the treatment of effluents
PH24632A (en) Tin diiododeuteroporphyrin and therapeutic use thereof
GB2040681B (en) Use in the treatment of hypertension and intestinal disorders of certain n - aryl - n - (2-imidazolidinylidene)-urea
DE3264378D1 (en) Medicaments for the treatment of obesity and hyperlipoidemia
EP0215200A3 (en) Use of sulfanilamido quinoxalines in the treatment of neoplastic diseases
EP0271127A3 (en) Use of guaifenesin in the treatment of urologic disorders
EP0453658A3 (en) Use of substituted anilides and sulfonamides in the treatment of cardiovascular diseases
EG14024A (en) Pharmaceutical compositions and their use in the profyloxis and or treatment of certain diseases
JPS5543094A (en) 3*44dihydroisoquinolines*their manufacture and their medical use
ZA87873B (en) Substituted diazapines and derivatives thereof useful in the treatment of cardiovascular disorders
JPS5527198A (en) Oligomer of pyridocarbazole and its therapeutic use
FR2594690B1 (en) REGENERATING AND STIMULATING COMPOSITIONS OF THE DERMIS
JPS5550362A (en) Fingerrpressure and massage instrument

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee